Preprint
Article

This version is not peer-reviewed.

Machine Learning Discoveries of BUB1-X Synergy in ETC-1922159 Treated Colorectal Cancer Cells

Submitted:

24 December 2024

Posted:

24 December 2024

You are already at the latest version

Abstract
The multidomain protein kinase, budding uninhibited by benzimidazoles 1 (BUB1) is a central component of the mitotic checkpoint for spindle assembly (SAC). It works with many different components. A recently developed search engine ranked combi- nations of mitotic checkpoint serine/threonine-protein kinase BUB1-X (X, a particular gene/protein) at 2nd order level after drug administration. Some of these rankings point to already confirmed wet lab results, while other point to possible BUB1-X syner- gistic combinations that might be working in CRC, but haven’t been tested/explored. In this research work, I cover combinations of BUB1 with spindle checkpoint pro- tein mitotic arrest deficient 2 (MAD2), inner centromere protein (INCENP), zwilch kinetochore protein (ZWILCH), aurora kinase (AURK), ZW10 interacting kinetochore protein (ZWINT), BUB-1B/3, centromere protein (CENP), cell division cycle (CDC), transforming growth factor beta (TGFB), DNA topoisomerase II (TOP), shugoshin (SGO), kinesin family member (KIF) and cyclin dependent kinase (CDK) family.
Keywords: 
;  ;  ;  

1. Introduction

1.1. Spindle Assembly Checkpoint

Zirkle [1] first observed that, when just one chromosome is retarded to arrive at the metaphase plate, anaphase onset is postponed until some minutes after its arrival. Later, Hoyt et al. [2] identified mutant strains of S. cerevisiae that fail to properly arrest their cell cycles at mitosis in response to the loss of microtubule function. Their studies defined three genes (BUB) required for normal cell cycle arrest. The multidomain protein kinases BUB1 and BUBR1 are central components of the mitotic checkpoint for spindle assembly (SAC). In most colorectal cancers, a chromosomal instability (CIN) leading to an abnormal chromosome number (aneuploidy) is observed Strand et al. [3]. Cahill et al. [4] show that CIN is associated with the loss of function of a mitotic checkpoint. In some cancers displaying CIN, the loss of this checkpoint was associated with the mutational inactivation of a human homologue of the yeast BUB1 gene. The normal mitotic checkpoints of cells displaying microsatellite instability become defective upon transfer of mutant hBUB1 alleles from either of two CIN cancers.
The missegregation of sister chromatids during mitosis results in the loss or gain of chromosomes in daughter cells (aneuploidy). To avoid this disastrous outcome, BUB works in synergy with multiple proteins (Bolanos-Garcia and Blundell [5]). Many of the different synergies represented as combinations of genes/proteins have been experimentally tested and published. However, there are combinations that have yet to be explored. I address the problem of identifying these unexplored combinations via use of a machine learning based search engine in the next section.

1.2. Combinatorial Search Problem and a Possible Solution

In a recently published work Sinha [6], a frame work of a search engine was developed which can rank combinations of factors (genes/proteins) in a signaling pathway. Readers are requested to go through the adaptation of the above mentioned work for gaining deeper insight into the working of the pipeline and its use of published data set generated after administration of ETC-1922159, Sinha [7]. The work uses SVM package by Joachims [8] in https://www.cs.cornell.edu/people/tj/svm_light/svm_rank.html. I use the adaptation to rank 2nd order gene combinations.

2. Results & Discussion

2.1. BUB1 Related Synergies

2.1.1. BUB1-MAD2/INCENP/ZWILCH/AURKB/ZWINT/BUB1B/BUB3

Johnson et al. [9] show that BUB1 plays a key role in the assembly of checkpoint proteins at the kinetochore. It is required for the subsequent localization of CENPF, BUBR1 (or BUB1B), CENPE and MAD2. Carvalhal et al. [10] state that proper kinetochore-microtubule attachments are supported by BUB1 dependent centromeric H2A-T120 phosphorylation, which promotes the recruitment of the chromosomal passenger complex, consisting of Aurora B (AURKB), inner centromere protein (INCENP), survivin, and borealin. BUB1 contributes to the recruitment of ROD-ZWILCH-ZW10 (RZZ) in human cells (Cheeseman and Desai [11] , Foley and Kapoor [12]). Wang et al. [13] show that AURKB phosphorylates HASPIN to promote generation of H3T3ph and that AURKB activity is required for normal chromosomal localization of the chromosomal passenger complex. This indicates an intimate linkage between AURKB and HASPIN functions in mitosis. They also propose that AURKB activity triggers a CPC-HASPIN-H3T3ph feedback loop that promotes generation of H3T3ph on chromatin and provide evidence that the BUB1-SGO-CPC pathway supplies a signal that boosts the CPC-HASPIN-H3T3ph feedback loop specifically at centromeres to produce the well-known accumulation of the CPC in these regions. Kiyomitsu et al. [14] show that the kinetochore target of BUBs in human cells is a kinetochore protein (blinkin), which interacts with ZWINT-1 (or ZWINT) and the two subunits hMis13 and hMis14 of the hMis12 complex. Bolanos-Garcia and Blundell [5] also state that BUBR1 (or BUB1B) forms part of the mitotic checkpoint complex (MCC) that contains BUB3, MAD2 and cell division cycle 20 (CDC20).
All the above experimental validations have been done and each of them were found to be down regulated in ETC-1922159 treated CRC. Individual recordings of these down regulations have been documented. Using the adaptation of the above mentioned search engine, I was able to rank 2nd order combination of MAD2 / INCENP / ZWILCH / AURKB / ZWINT / BUB1B / BUB3 with BUB1, that were down regulated.
Table 1 shows rankings of these combinations. Followed by this is the unexplored combinatorial hypotheses in Table 2 generated from analysis of the ranks in Table 1. The Table 1 shows rankings of individual members w.r.t BUB1. MAD2L1 - BUB1 shows low ranking of 227 (laplace) and 17 (rbf). MAD2L2 - BUB1 shows low ranking of 977 (laplace) and 219 (linear). INCENP - BUB1 shows low ranking of 959 (laplace), 842 (linear) and 1188 (rbf). ZWILCH - BUB1 shows low ranking of 345 (laplace) and 1561 (linear). AURKB - BUB1 shows low ranking of 97 (laplace) and 491 (linear). ZWINT - BUB1 shows low ranking of 219 (laplace), 187 (linear) and 27 (rbf). BUB3 - BUB1 shows low ranking of 1657 (laplace) and 1042 (rbf). These rankings point to the synergy existing between the two components, which have been down regulated after the drug treatment. AURKA and BUB1B did not show synergistic down regulation with BUB1.
One can also interpret the results of the Table 1 graphically, with the following influences - • Individual members w.r.t BUB1 with BUB1 > MAD2-L1/L2; BUB1 > INCENP; BUB1 > ZWILCH; BUB1 > AURKB; BUB1 > ZWINT; and BUB1 > BUB3.

2.1.2. BUB1-CENP Family

Johnson et al. [9] show that BUB1 plays a key role in the assembly of checkpoint proteins at the kinetochore. It is required for the subsequent localization of CENPF, BUBR1 (or BUB1B), CENPE and MAD2. Johnson et al. [9] also mention a number of proteins, including CENPA, CENPC and CENPI, that localize to the centromere region throughout the cell cycle and many other proteins only localize to kinetochores transiently during mitosis, while pointing to relevant literature. All the above experimental validations have been done and each of them were found to be down regulated in ETC-1922159 treated CRC. Individual recordings of these down regulations have been documented. I was able to rank 2nd order combination of CENP family members with BUB1, that were down regulated. Rankings confirm some of the existing combinations while giving insight about unexplored combinations also.
Table 3 shows rankings of these combinations. Followed by this is the unexplored combinatorial hypotheses in Table 4 generated from analysis of the ranks in Table 3. The Table 3 shows rankings of CENP family w.r.t BUB1. CENPH - BUB1 shows low ranking of 43 (laplace), 261 (linear) and 482 (rbf). CENPA - BUB1 shows low ranking of 67 (laplace), 41 (linear) and 31 (rbf). CENPM - BUB1 shows low ranking of 90 (laplace), 1492 (linear) and 1105 (rbf). CENPJ - BUB1 shows low ranking of 142 (laplace), 69 (linear) and 1484 (rbf). CENPU - BUB1 shows low ranking of 342 (laplace), 632 (linear) and 852 (rbf). CENPE - BUB1 shows low ranking of 385 (laplace) and 105 (linear). CENPF - BUB1 shows low ranking of 606 (laplace), 430 (linear) and 1419 (rbf). CENPK - BUB1 shows low ranking of 607 (laplace), 3 (linear) and 1371 (rbf). CENPI - BUB1 shows low ranking of 672 (laplace), 170 (linear). CENPW - BUB1 shows low ranking of 730 (laplace), 64 (linear) and 304 (rbf). CENPN - BUB1 shows low ranking of 917 (laplace), 482 (linear) and 447 (rbf). These rankings point to the synergy existing between the two components, which have been down regulated after the drug treatment. CENPO, CENPL and CENPV did not show synergistic down regulation with BUB1.
One can also interpret the results of the Table 3 graphically, with the following influences - • CENP family w.r.t BUB1 with BUB1 > CENP-H/A/M/J/U/E/F/K/I/W/N.

2.1.3. BUB1-CDC Family

Goto et al. [15] suggest that CDC28 mediates phosphorylation of BUB1 at T566. This plays an important role for the degradation of BUB1 in anaphase, and the phosphorylation is required for adaptation of the spindle checkpoint to prolonged mitotic arrest. Bolanos-Garcia and Blundell [5] depict a model where BUB1 KEN boxes mediate BUB1 degradation by the APC/C–CDH1 in the G1 phase of the cell cycle and BUB1–CDC20 binding. Phosphorylation of CDC20 S153 by BUB1 is required for efficient SAC activity. All the above experimental validations have been done and each of them were found to be down regulated in ETC-1922159 treated CRC. Individual recordings of these down regulations have been documented. I was able to rank 2nd order combination of CDC family members with BUB1, that were down regulated. Rankings confirm some of the existing combinations while giving insight about unexplored combinations also.
Table 5 shows rankings of these combinations. Followed by this is the unexplored combinatorial hypotheses in Table 6 generated from analysis of the ranks in Table 5. The Table 5 shows rankings of CDC family w.r.t BUB1. CDC45 - BUB1 shows low ranking of 12 (laplace) and 228 (rbf). CDC25C - BUB1 shows low ranking of 53 (laplace), 303 (linear) and 188 (rbf). CDC20 - BUB1 shows low ranking of 253 (laplace) and 362 (rbf). CDC7 - BUB1 shows low ranking of 305 (laplace), 34 (linear) and 853 (rbf). CDC6 - BUB1 shows low ranking of 647 (laplace), 776 (linear) and 444 (rbf). CDC25A - BUB1 shows low ranking of 853 (laplace) and 447 (linear). These rankings point to the synergy existing between the two components, which have been down regulated after the drug treatment. CDC23 and CDC123 did not show synergistic down regulation with BUB1.
One can also interpret the results of the Table 5 graphically, with the following influences - • CDC family w.r.t BUB1 with BUB1 > CDC-45/25C/20/7/6/25A.

2.1.4. BUB1-TGF β Family

Nyati et al. [16] identified BUB1 as a mediator of TGF β signaling. BUB1 interacted with TGFBRI in response to stimulation with TGF β and promoted the heterodimerization of TGFBRI and TGFBRII. Nyati et al. [17] demonstrate that TGFBR2 phosphorylates BUB1 at Serine-318. All the above experimental validations have been done and each of them were found to be down regulated in ETC-1922159 treated CRC. Individual recordings of these down regulations have been documented. I was able to rank 2nd order combination of TGF β family members with BUB1, that were down regulated.
Table 7 shows rankings of these combinations. Followed by this is the unexplored combinatorial hypotheses in Table 8 generated from analysis of the ranks in Table 7. The Table 7 shows rankings of TGF β family w.r.t BUB1. TGFBR3 - BUB1 shows low ranking of 1066 (laplace), 890 (linear) and 1525 (rbf). TGFB1 - BUB1 shows low ranking of 1350 (linear) and 1000 (rbf). These rankings point to the synergy existing between the two components, which have been down regulated after the drug treatment. TGFBRAP1 did not show synergistic down regulation with BUB1.
One can also interpret the results of the Table 7 graphically, with the following influences - • TGF β family w.r.t BUB1 with BUB1 > TGF β -R3/1.

2.1.5. BUB1-TOP Family

Chromosome segregation in mitosis requires the removal of catenation between sister chromatids. Timely decatenation of sister DNAs at mitotic centromeres by topoisomerase IIa (TOP2A) is crucial to maintain genomic stability. Zhang et al. [18] show that BUB1 generated modification, that is histone H2A Thr-120 phosphorylation (H2ApT120), is necessary and sufficient for the centromeric localization of TOP2A. Individual recordings of these down regulations have been documented. All the above experimental validations have been done and each of them were found to be down regulated in ETC-1922159 treated CRC. I was able to rank 2nd order combination of TOP family members with BUB1, that were down regulated.
Table 9 shows rankings of these combinations. Followed by this is the unexplored combinatorial hypotheses in Table 10 generated from analysis of the ranks in Table 9. The Table 9 shows rankings of TOP family w.r.t BUB1. TOP2A - BUB1 shows low ranking of 392 (laplace), 423 (linear) and 984 (rbf). TOP1MT - BUB1 shows low ranking of 884 (laplace) and 476 (linear). These rankings point to the synergy existing between the two components, which have been down regulated after the drug treatment. TOP2B and TOPBP1 did not show synergistic down regulation with BUB1.
One can also interpret the results of the Table 9 graphically, with the following influences - • TOP family w.r.t BUB1 with BUB1 > TOP-2A/1MT.

2.1.6. BUB1-SGO Family

Salic et al. [19] demonstrate that the vertebrate SGO localizes to kinetochores and is required to prevent premature sister centromere separation in mitosis. Further, Tang et al. [20] show that human BUB1 protects centromeric sister-chromatid cohesion through SGO during mitosis. All the above experimental validations have been done and each of them were found to be down regulated in ETC-1922159 treated CRC. Individual recordings of these down regulations have been documented. I was able to rank 2nd order combination of SGO family members with BUB1, that were down regulated.
Table 11 shows rankings of these combinations. Followed by this is the unexplored combinatorial hypotheses in Table 12 generated from analysis of the ranks in Table 11. The Table 11 shows rankings of SGO family w.r.t BUB1. SGOL1 - BUB1 shows low ranking of 336 (laplace) and 123 (linear). SGOL2 - BUB1 shows low ranking of 537 (laplace) and 115 (linear). SGOL1.AS1 - BUB1 shows low ranking of 637 (laplace), 4 (linear) and 1494 (rbf). These rankings point to the synergy existing between the two components, which have been down regulated after the drug treatment. SGO2B and SGOBP1 did not show synergistic down regulation with BUB1.
One can also interpret the results of the Table 11 graphically, with the following influences - • SGO family w.r.t BUB1 with BUB1 > SGO-L1/L2/L1.AS1.

2.1.7. BUB1-KIF Family

Jiang et al. [21] in their study, found that BUB1 expression was increased in human bladder cancer (BCa). They identified that BUB1 interacted directly with STAT3 and mediated the phosphorylation of STAT3 at Ser727. Finally, they also found that the BUB1/STAT3 complex promoted the transcription of STAT3 target genes. To confirm this conclusion, they performed qRT–PCR by knocking down BUB1 with siRNA, and the results showed that the transcriptional activity of STAT3 was significantly reduced and that the expression of STAT3 target genes, like E2F3, KIF18B, etc. , was diminished. Individual recordings of these down regulations have been documented. All the above experimental validations have been done and each of them were found to be down regulated in ETC-1922159 treated CRC. I was able to rank 2nd order combination of KIF family members with BUB1, that were down regulated.
Table 13 shows rankings of these combinations. Followed by this is the unexplored combinatorial hypotheses in Table 14 generated from analysis of the ranks in Table 13. The Table 13 shows rankings of KIF family w.r.t BUB1. KIF18B - BUB1 shows low ranking of 14 (laplace), 1575 (linear) and 310 (rbf). KIF15 - BUB1 shows low ranking of 19 (laplace), 92 (linear) and 238 (rbf). KIF20A - BUB1 shows low ranking of 224 (laplace) and 117 (linear). KIF22 - BUB1 shows low ranking of 252 (laplace), 121 (linear) and 424 (rbf). KIF2C - BUB1 shows low ranking of 254 (laplace), 110 (linear) and 1197 (rbf). KIF20B - BUB1 shows low ranking of 258 (laplace) and 824 (linear). KIF18A - BUB1 shows low ranking of 285 (laplace), 47 (linear) and 10 (rbf). KIF4A - BUB1 shows low ranking of 362 (laplace) and 120 (linear). KIF23 - BUB1 shows low ranking of 399 (laplace) and 1111 (rbf). KIF9 - BUB1 shows low ranking of 497 (laplace), 580 (linear) and 1530 (rbf). KIF11 - BUB1 shows low ranking of 541 (laplace) and 1362 (linear). KIF7 - BUB1 shows low ranking of 1063 (laplace), 1171 (linear) and 616 (rbf). KIF27 - BUB1 shows low ranking of 1362 (linear) and 633 (rbf). These rankings point to the synergy existing between the two components, which have been down regulated after the drug treatment. KIF14 and KIF13A did not show synergistic down regulation with BUB1.
One can also interpret the results of the Table 13 graphically, with the following influences - • KIF family w.r.t BUB1 with BUB1 > KIF-18B/15/20A/22/2C/20B/18A/4A/23/9/11/7/27.

2.1.8. BUB1-CDK Family

Vazquez-Novelle et al. [22] show that CDK1 inactivation terminates mitotic checkpoint surveillance and stabilizes kinetochore attachments in anaphase. Ji et al. [23] show that phosphorylation of BUB1 by CDK1 is required for the spindle checkpoint. All the above experimental validations have been done and each of them were found to be down regulated in ETC-1922159 treated CRC. Individual recordings of these down regulations have been documented. Using the adaptation of the above mentioned search engine, I was able to rank 2nd order combination of CDK family members with BUB1, that were down regulated.
Table 15 shows rankings of these combinations. Followed by this is the unexplored combinatorial hypotheses in Table 16 generated from analysis of the ranks in Table 15. The Table 15 shows rankings of CDK family w.r.t BUB1. CDK20 - BUB1 shows low ranking of 1070 (laplace) and 577 (rbf). CDK6 - BUB1 shows low ranking of 1005 (linear) and 426 (rbf). These rankings point to the synergy existing between the two components, which have been down regulated after the drug treatment. CDK5-RAP1/RAP2 and CDK4 did not show synergistic down regulation with BUB1.
One can also interpret the results of the Table 15 graphically, with the following influences - • CDK family w.r.t BUB1 with BUB1 > CDK-20/6.

3. Conclusion

Presented here are a range of multiple synergistic BUB1 2nd order combinations that were ranked via a machine learning based search engine. Via majority voting across the ranking methods, it was possible to find plausible unexplored synergistic combinations of BUB1-X that might be prevalent in CRC cells after treatment with ETC-1922159 drug.

Author Contributions

Concept, design, in silico implementation - SS. Analysis and interpretation of results - SS. Manuscript writing - SS. Manuscript revision - SS. Approval of manuscript - SS

Acknowledgments

Special thanks to Mrs. Rita Sinha and Mr. Prabhat Sinha for supporting the author financially, without which this work could not have been made possible.

Conflicts of Interest

There are no conflicts to declare.

Source of Data

Data used in this research work was released in a publication in Madan et al. [24]. The ETC-1922159 was released in Singapore in July 2015 under the flagship of the Agency for Science, Technology and Research (A*STAR) and Duke-National University of Singapore Graduate Medical School (Duke-NUS).

References

  1. Zirkle, R.E. Ultraviolet-microbeam irradiation of newt-cell cytoplasm: spindle destruction, false anaphase, and delay of true anaphase. Radiation research 1970, 41, 516–537. [Google Scholar] [CrossRef] [PubMed]
  2. Hoyt, M.A.; Totis, L.; Roberts, B.T. S. cerevisiae genes required for cell cycle arrest in response to loss of microtubule function. Cell 1991, 66, 507–517. [Google Scholar] [CrossRef] [PubMed]
  3. Strand, M.; Prolla, T.A.; Liskay, R.M.; Petes, T.D. Destabilization of tracts of simple repetitive DNA in yeast by mutations affecting DNA mismatch repair. Nature 1993, 365, 274–276. [Google Scholar] [CrossRef] [PubMed]
  4. Cahill, D.P.; Lengauer, C.; Yu, J.; Riggins, G.J.; Willson, J.K.; Markowitz, S.D.; Kinzler, K.W.; Vogelstein, B. Mutations of mitotic checkpoint genes in human cancers. Nature 1998, 392, 300–303. [Google Scholar] [CrossRef] [PubMed]
  5. Bolanos-Garcia, V.M.; Blundell, T.L. BUB1 and BUBR1: multifaceted kinases of the cell cycle. Trends in biochemical sciences 2011, 36, 141–150. [Google Scholar] [CrossRef] [PubMed]
  6. Sinha, S. Machine learning ranking of plausible (un) explored synergistic gene combinations using sensitivity indices of time series measurements of Wnt signaling pathway. Integrative Biology 2024, 16, zyae020. [Google Scholar] [CrossRef]
  7. Sinha, S. Sensitivity analysis based ranking reveals unknown biological hypotheses for down regulated genes in time buffer during administration of PORCN-WNT inhibitor ETC-1922159 in CRC. bioRxiv 2017, p. 180927.
  8. Joachims, T. Training linear SVMs in linear time. In Proceedings of the Proceedings of the 12th ACM SIGKDD international conference on Knowledge discovery and data mining. ACM, 2006, pp. 217–226.
  9. Johnson, V.L.; Scott, M.I.; Holt, S.V.; Hussein, D.; Taylor, S.S. Bub1 is required for kinetochore localization of BubR1, Cenp-E, Cenp-F and Mad2, and chromosome congression. Journal of cell science 2004, 117, 1577–1589. [Google Scholar] [CrossRef]
  10. Carvalhal, S.; Bader, I.; Rooimans, M.A.; Oostra, A.B.; Balk, J.A.; Feichtinger, R.G.; Beichler, C.; Speicher, M.R.; van Hagen, J.M.; Waisfisz, Q.; et al. Biallelic BUB1 mutations cause microcephaly, developmental delay, and variable effects on cohesion and chromosome segregation. Science advances 2022, 8, eabk0114. [Google Scholar] [CrossRef] [PubMed]
  11. Cheeseman, I.M.; Desai, A. Molecular architecture of the kinetochore–microtubule interface. Nature reviews Molecular cell biology 2008, 9, 33–46. [Google Scholar] [CrossRef] [PubMed]
  12. Foley, E.A.; Kapoor, T.M. Microtubule attachment and spindle assembly checkpoint signalling at the kinetochore. Nature reviews Molecular cell biology 2013, 14, 25–37. [Google Scholar] [CrossRef]
  13. Wang, F.; Ulyanova, N.P.; van der Waal, M.S.; Patnaik, D.; Lens, S.M.; Higgins, J.M. A positive feedback loop involving Haspin and Aurora B promotes CPC accumulation at centromeres in mitosis. Current Biology 2011, 21, 1061–1069. [Google Scholar] [CrossRef] [PubMed]
  14. Kiyomitsu, T.; Obuse, C.; Yanagida, M. Human Blinkin/AF15q14 is required for chromosome alignment and the mitotic checkpoint through direct interaction with Bub1 and BubR1. Developmental cell 2007, 13, 663–676. [Google Scholar] [CrossRef] [PubMed]
  15. Goto, G.H.; Mishra, A.; Abdulle, R.; Slaughter, C.A.; Kitagawa, K. Bub1-mediated adaptation of the spindle checkpoint. PLoS Genetics 2011, 7, e1001282. [Google Scholar] [CrossRef] [PubMed]
  16. Nyati, S.; Schinske-Sebolt, K.; Pitchiaya, S.; Chekhovskiy, K.; Chator, A.; Chaudhry, N.; Dosch, J.; Van Dort, M.E.; Varambally, S.; Kumar-Sinha, C.; et al. The kinase activity of the Ser/Thr kinase BUB1 promotes TGF-β signaling. Science signaling 2015, 8, ra1–ra1. [Google Scholar] [CrossRef]
  17. Nyati, S.; Gregg, B.S.; Xu, J.; Young, G.; Kimmel, L.; Nyati, M.K.; Ray, D.; Speers, C.; Rehemtulla, A. TGFBR2 mediated phosphorylation of BUB1 at Ser-318 is required for transforming growth factor-β signaling. Neoplasia 2020, 22, 163–178. [Google Scholar] [CrossRef] [PubMed]
  18. Zhang, M.; Liang, C.; Chen, Q.; Yan, H.; Xu, J.; Zhao, H.; Yuan, X.; Liu, J.; Lin, S.; Lu, W.; et al. Histone H2A phosphorylation recruits topoisomerase II α to centromeres to safeguard genomic stability. The EMBO Journal 2020, 39, e101863. [Google Scholar] [CrossRef] [PubMed]
  19. Salic, A.; Waters, J.C.; Mitchison, T.J. Vertebrate shugoshin links sister centromere cohesion and kinetochore microtubule stability in mitosis. Cell 2004, 118, 567–578. [Google Scholar] [CrossRef] [PubMed]
  20. Tang, Z.; Sun, Y.; Harley, S.E.; Zou, H.; Yu, H. Human Bub1 protects centromeric sister-chromatid cohesion through Shugoshin during mitosis. Proceedings of the National Academy of Sciences 2004, 101, 18012–18017. [Google Scholar] [CrossRef]
  21. Jiang, N.; Liao, Y.; Wang, M.; Wang, Y.; Wang, K.; Guo, J.; Wu, P.; Zhong, B.; Guo, T.; Wu, C. BUB1 drives the occurrence and development of bladder cancer by mediating the STAT3 signaling pathway. Journal of Experimental & Clinical Cancer Research 2021, 40, 1–17. [Google Scholar]
  22. Vazquez-Novelle, M.D.; Sansregret, L.; Dick, A.E.; Smith, C.A.; McAinsh, A.D.; Gerlich, D.W.; Petronczki, M. Cdk1 inactivation terminates mitotic checkpoint surveillance and stabilizes kinetochore attachments in anaphase. Current Biology 2014, 24, 638–645. [Google Scholar] [CrossRef]
  23. Ji, Z.; Gao, H.; Jia, L.; Li, B.; Yu, H. A sequential multi-target Mps1 phosphorylation cascade promotes spindle checkpoint signaling. Elife 2017, 6, e22513. [Google Scholar] [CrossRef] [PubMed]
  24. Madan, B.; Ke, Z.; Harmston, N.; Ho, S.Y.; Frois, A.; Alam, J.; Jeyaraj, D.A.; Pendharkar, V.; Ghosh, K.; Virshup, I.H.; et al. Wnt addiction of genetically defined cancers reversed by PORCN inhibition. Oncogene 2016, 35, 2197. [Google Scholar] [CrossRef]
Table 1. 2nd order interaction ranking between BUB1 VS Individual members.
Table 1. 2nd order interaction ranking between BUB1 VS Individual members.
Ranking Individual members VS BUB1
Ranking of Individual members w.r.t BUB1
laplace linear rbf
MAD2L1 - BUB1 227 2601 17
MAD2L2 - BUB1 977 219 2067
INCENP - BUB1 959 842 1188
ZWILCH - BUB1 345 1561 2722
AURKA - BUB1 1008 1835 2613
AURKB - BUB1 97 491 2561
ZWINT - BUB1 219 187 27
BUB1B - BUB1 41 2188 2031
BUB3 - BUB1 1657 2711 1042
Table 2. 2nd order combinatorial hypotheses between BUB1 and Individual members.
Table 2. 2nd order combinatorial hypotheses between BUB1 and Individual members.
Unexplored combinatorial hypotheses
Individual members w.r.t BUB1
MAD2-L1/L2 BUB1
INCENP BUB1
ZWILCH BUB1
AURKB BUB1
ZWINT BUB1
BUB3 BUB1
Table 3. 2nd order interaction ranking between BUB1 VS CENP family members.
Table 3. 2nd order interaction ranking between BUB1 VS CENP family members.
Ranking CENP family VS BUB1
Ranking of CENP family w.r.t BUB1
laplace linear rbf
CENPH - BUB1 43 261 482
CENPA - BUB1 67 41 31
CENPM - BUB1 90 1492 1105
CENPJ - BUB1 142 69 1484
CENPU - BUB1 342 632 852
CENPE - BUB1 385 105 2360
CENPF - BUB1 606 430 1419
CENPK - BUB1 607 3 1371
CENPO - BUB1 650 2578 1694
CENPI - BUB1 672 170 2384
CENPW - BUB1 730 64 304
CENPL - BUB1 819 1994 2181
CENPN - BUB1 917 482 447
CENPV - BUB1 1955 1423 2226
Table 4. 2nd order combinatorial hypotheses between BUB1 and CENP family members.
Table 4. 2nd order combinatorial hypotheses between BUB1 and CENP family members.
Unexplored combinatorial hypotheses
CENP family w.r.t BUB1
CENP-H/A/M/J/U/E/F/K/I/W/N BUB1
Table 5. 2nd order interaction ranking between BUB1 VS CDC family members.
Table 5. 2nd order interaction ranking between BUB1 VS CDC family members.
Ranking CDC family VS BUB1
Ranking of CDC family w.r.t BUB1
laplace linear rbf
CDC45 - BUB1 12 2527 228
CDC25C - BUB1 53 303 188
CDC20 - BUB1 253 2321 362
CDC7 - BUB1 305 34 853
CDC6 - BUB1 647 776 444
CDC25A - BUB1 853 447 2216
CDC23 - BUB1 1672 1018 1775
CDC123 - BUB1 2292 2633 1366
Table 6. 2nd order combinatorial hypotheses between BUB1 and CDC family members.
Table 6. 2nd order combinatorial hypotheses between BUB1 and CDC family members.
Unexplored combinatorial hypotheses
CDC family w.r.t BUB1
CDC-45/25C/20/7/6/25A BUB1
Table 7. 2nd order interaction ranking between BUB1 VS TGF β family members.
Table 7. 2nd order interaction ranking between BUB1 VS TGF β family members.
Ranking TGF β family VS BUB1
Ranking of TGF β family w.r.t BUB1
laplace linear rbf
TGFBR3 - BUB1 1066 890 1525
TGFBRAP1 - BUB1 2332 1239 1867
TGFB1 - BUB1 2549 1350 1000
Table 8. 2nd order combinatorial hypotheses between BUB1 and TGF β family members.
Table 8. 2nd order combinatorial hypotheses between BUB1 and TGF β family members.
Unexplored combinatorial hypotheses
TGF β family w.r.t BUB1
TGFB-R3/1 BUB1
Table 9. 2nd order interaction ranking between BUB1 VS TOP family members.
Table 9. 2nd order interaction ranking between BUB1 VS TOP family members.
Ranking TOP family VS BUB1
Ranking of TOP family w.r.t BUB1
laplace linear rbf
TOP2A - BUB1 392 423 984
TOP1MT - BUB1 884 476 2088
TOP2B - BUB1 2261 2606 347
TOPBP1 - BUB1 2300 2288 346
Table 10. 2nd order combinatorial hypotheses between BUB1 and TOP family members.
Table 10. 2nd order combinatorial hypotheses between BUB1 and TOP family members.
Unexplored combinatorial hypotheses
TOP family w.r.t BUB1
TOP-2A/1MT BUB1
Table 11. 2nd order interaction ranking between BUB1 VS SGO family members.
Table 11. 2nd order interaction ranking between BUB1 VS SGO family members.
Ranking SGO family VS BUB1
Ranking of SGO family w.r.t BUB1
laplace linear rbf
SGOL1 - BUB1 336 123 2393
SGOL2 - BUB1 537 115 1838
SGOL1.AS1 - BUB1 637 4 1494
Table 12. 2nd order combinatorial hypotheses between BUB1 and SGO family members.
Table 12. 2nd order combinatorial hypotheses between BUB1 and SGO family members.
Unexplored combinatorial hypotheses
SGO family w.r.t BUB1
SGO-L1/L2/L1.AS1 BUB1
Table 13. 2nd order interaction ranking between BUB1 VS KIF family members.
Table 13. 2nd order interaction ranking between BUB1 VS KIF family members.
Ranking KIF family VS BUB1
Ranking of KIF family w.r.t BUB1
laplace linear rbf laplace linear rbf
KIF18B - BUB1 14 1575 310 KIF15 - BUB1 19 92 238
KIF14 - BUB1 86 2186 1935 KIF20A - BUB1 224 117 2559
KIF22 - BUB1 252 121 424 KIF2C - BUB1 254 110 1197
KIF20B - BUB1 258 824 2622 KIF18A - BUB1 285 47 10
KIF4A - BUB1 362 120 1949 KIF23 - BUB1 399 2594 1111
KIF9 - BUB1 497 580 1530 KIF11 - BUB1 541 1362 2246
KIF7 - BUB1 1063 1171 616 KIF27 - BUB1 2011 1362 633
KIF13A - BUB1 2680 2159 1966
Table 14. 2nd order combinatorial hypotheses between BUB1 and KIF family members.
Table 14. 2nd order combinatorial hypotheses between BUB1 and KIF family members.
Unexplored combinatorial hypotheses
KIF family w.r.t BUB1
KIF-18B/15/20A/22/2C/20B/18A/4A/23/9/11/7/27 BUB1
Table 15. 2nd order interaction ranking between BUB1 VS CDK family members.
Table 15. 2nd order interaction ranking between BUB1 VS CDK family members.
Ranking CDK family VS BUB1
Ranking of CDK family w.r.t BUB1
laplace linear rbf
CDK20 - BUB1 1070 2521 577
CDK6 - BUB1 1713 1005 426
CDK5RAP1 - BUB1 1883 2223 2029
CDK4 - BUB1 1992 2056 1684
CDK5RAP2 - BUB1 2347 1751 1112
Table 16. 2nd order combinatorial hypotheses between BUB1 and CDK family members.
Table 16. 2nd order combinatorial hypotheses between BUB1 and CDK family members.
Unexplored combinatorial hypotheses
CDK family w.r.t BUB1
CDK-20/6 BUB1
Disclaimer/Publisher’s Note: The statements, opinions and data contained in all publications are solely those of the individual author(s) and contributor(s) and not of MDPI and/or the editor(s). MDPI and/or the editor(s) disclaim responsibility for any injury to people or property resulting from any ideas, methods, instructions or products referred to in the content.
Copyright: This open access article is published under a Creative Commons CC BY 4.0 license, which permit the free download, distribution, and reuse, provided that the author and preprint are cited in any reuse.
Prerpints.org logo

Preprints.org is a free preprint server supported by MDPI in Basel, Switzerland.

Subscribe

Disclaimer

Terms of Use

Privacy Policy

Privacy Settings

© 2025 MDPI (Basel, Switzerland) unless otherwise stated